Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-794-9 | CAS number: 110-71-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2 November - 10 November 1982
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Well performed guideline study.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 982
- Report date:
- 1982
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- yes
- Remarks:
- early sample collection
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- 1,2-dimethoxyethane
- EC Number:
- 203-794-9
- EC Name:
- 1,2-dimethoxyethane
- Cas Number:
- 110-71-4
- Molecular formula:
- C4H10O2
- IUPAC Name:
- 1,2-dimethoxyethane
- Details on test material:
- colorless clear liquid
Purity: > 99%
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- 50 NMRI mice (Hoe NMRKf(SPF71, Breeder: Pharma Forschung Toxikologe, Kastengrund, Germany)
Age: 7-12 weeks
Body weight:
- male: 30-38 g (mean: 33 g)
- female: 23-27 g (mean: 25 g)
Housing: groups of five animals in Makrolon type-3 cages with wire mesh tops and softwood bedding
Diet: pelleted Altromin diet 1324 ad libitum
Water: Community tap-water, ad libitum
Room temperature: 22-24°C
Humidity: 41-49%
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- deionised water
- Details on exposure:
- A pre study revealed that 2000 mg/kg bw/d was the maximum tolerated dose.
Treatment:
Five males and five females were assigned to each test group. Animals were treated orally twice (one application per day) with either three doses of the test substance, the positive control (Cyclophosphamide) or the vehicle control (deinised water). Six hours after the last application the bone marrow of the animals was prepared.
Preparation of the animals:
The animals were killed and the femora were removed, the epiphyses were cut off and the marrow was flushed out with foetal calf serum using a syringe. The cell suspension was centrifuged at 1000 rpm for 5 min and the supernatant was discarded. A small drop of re-suspended cell pellet was spread on a slide. The smear was air-dried and stained with May-Grünwald/Giemsa.
Bone marrow smears were scored microscopically for micronucleated polychrmoatic erythrocytes. To analyse target organ cytotoxicity the ratio between polychrmoatic and normochromatic erythrocytes was determined. 2000 polychromatic erythrocytes per animal were analysed for appearance of micronuclei. The count of micronuclei containing normocytes was determined. - Duration of treatment / exposure:
- 2 applications (one per day)
- Frequency of treatment:
- daily
- Post exposure period:
- 6 hours
Doses / concentrationsopen allclose all
- Dose / conc.:
- 20 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 200 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 2 000 mg/kg bw/day (actual dose received)
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Cyclophosphamide 100 mg/kg bw/d
Examinations
- Tissues and cell types examined:
- Please refer to "Details on exposure"
- Details of tissue and slide preparation:
- Please refer to "Details on exposure"
- Evaluation criteria:
- 5 animals per group and sex and 2000 polychromatic erythrocytes per animal were evaluated.
- Statistics:
- Performed by computer programm "Diamant" (Code: SG-PA Nr. 4453) programmed by the Department of Praktische Methamatik of the Hoechst AG, Frankfurt, Germany.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not specified
- Positive controls validity:
- valid
- Additional information on results:
- Please refer to "Remarks on results"
Any other information on results incl. tables
Results of in vivo Micronucleus Test in NMRI-Mice (males)
Dose |
Animal |
MN1/ |
MN1/ |
Ratio |
|
|
|
|
|
Control |
1 |
6 |
1 |
751:1000 |
|
2 |
9 |
2 |
725:1000 |
|
3 |
5 |
3 |
865:1000 |
|
4 |
9 |
1 |
839:1000 |
|
5 |
8 |
1 |
858:1000 |
20 |
11 |
6 |
1 |
966:1000 |
|
12 |
10 |
4 |
748:1000 |
|
13 |
7 |
1 |
823:1000 |
|
14 |
10 |
3 |
823:1000 |
|
15 |
8 |
2 |
607:1000 |
200 |
21 |
5 |
2 |
710:1000 |
|
22 |
4 |
4 |
796:1000 |
|
23 |
7 |
2 |
791:1000 |
|
24 |
7 |
3 |
1063:1000 |
|
25 |
9 |
1 |
663:1000 |
2000 |
31 |
5 |
2 |
969:1000 |
|
32 |
3 |
2 |
1217:1000 |
|
33 |
7 |
4 |
673:1000 |
|
34 |
8 |
1 |
767:1000 |
|
35 |
14 |
2 |
956:1000 |
Cyclophosphamide |
41 |
154 |
2 |
649:1000 |
|
42 |
184 |
3 |
343:1000 |
|
43 |
162 |
3 |
489:1000 |
|
44 |
165 |
4 |
440:1000 |
|
45 |
211 |
4 |
450:1000 |
|
|
|
|
|
1 Micronuclei
2 polychromatic erythrocytes
3 Normocytes Results of in vivo Micronucleus Test in NMRI-Mice (females)
Dose |
Animal |
MN1/ |
MN1/ |
Ratio |
|
|
|
|
|
Control |
6 |
4 |
0 |
920:1000 |
|
7 |
1 |
1 |
907:1000 |
|
8 |
8 |
1 |
1126:1000 |
|
9 |
6 |
2 |
891:1000 |
|
10 |
9 |
2 |
1098:1000 |
20 |
16 |
8 |
5 |
1054:1000 |
|
17 |
5 |
1 |
851:1000 |
|
18 |
5 |
3 |
851:1000 |
|
19 |
4 |
1 |
986:1000 |
|
20 |
6 |
1 |
913:1000 |
200 |
26 |
5 |
1 |
928:1000 |
|
27 |
5 |
4 |
1336:1000 |
|
28 |
5 |
0 |
961:1000 |
|
29 |
5 |
2 |
838:1000 |
|
30 |
10 |
2 |
1195:1000 |
2000 |
36 |
8 |
1 |
991:1000 |
|
37 |
5 |
2 |
1350:1000 |
|
38 |
9 |
3 |
916:1000 |
|
39 |
9 |
4 |
1223:1000 |
|
40 |
10 |
2 |
1205:1000 |
Cyclophosphamide |
46 |
122 |
2 |
496:1000 |
|
47 |
70 |
1 |
563:1000 |
|
48 |
148 |
1 |
345:1000 |
|
49 |
134 |
2 |
512:1000 |
|
50 |
146 |
4 |
446:1000 |
|
|
|
|
|
1 Micronuclei
2 polychromatic erythrocytes
3 Normocytes
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results: negative
Ethylene glycol dimethyl ether is considered to be non-mutagenic in the micronucleus assay. - Executive summary:
Animals treated with up to 2000 mg/kg bw/d (2 applications, one daily) did not show any clinical sign. All animals survived until the study termination.
The number of micronuclei containing polychromatic erythrocytes and normocytes were not influenced by the treatment with Ethylene glycol dimethyl ether. The ratio polychromatic erythrocytes/normocytes did not differ to the ratio obtained from the negative control animals.
Cyclophosphamide (positive control) showed a significant increase of induced mirconucleus frequency.
In conclusion, it can be stated that during the study the test item did not induce micronuclei as determined by the micronucleus test in the bone marrow cells of the mouse.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.